Endostart - About the company
Endostart is a series A company based in Certaldo (Italy), founded in 2018 by Alessandro Tozzi. It operates as a Developer of a guiding system for colonoscopy procedures. Endostart has raised $19.2M in funding from investors like Panakes Partners, LIFTT and HTH. The company has 158 active competitors, including 68 funded and 26 that have exited. Its top competitors include companies like Augmedics, ClearPoint Neuro and Proprio.
Company Details
Developer of a guiding system for colonoscopy procedures. The company has developed the Endorail system which consists of a magnetic balloon guide, ferrofluid syringe, and multiuse magnetic handpiece which guides the colonoscope thus reducing the wall stress and need for general anesthesia.
- Website
- endostart.com
- Email ID
- *****@endostart.com
- Phone Number
- +39 **********
Key Metrics
Founded Year
2018
Location
Certaldo, Italy
Stage
Series A
Total Funding
$19.2M in 3 rounds
Latest Funding Round
Investors
Ranked
38th among 158 active competitors
Employee Count
19 as on Jun 30, 2026
Sign up to download Endostart's company profile
Endostart's funding and investors
Endostart has raised a total funding of $19.2M over 3 rounds. Its first funding round was on Dec 20, 2018. Its latest funding round was a Series A round on Sep 12, 2022 for $*****. 1 investor participated in its latest round. Endostart has 8 institutional investors.
Here is the list of recent funding rounds of Endostart:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 12, 2022 | 7983725 | Series A | 3471920 | 9348216 | 7081098 | 2611480 |
Jun 04, 2021 | 6679676 | Series A | 4408564 | 7866585 | 2863589 | 7463065 |
Dec 20, 2018 | 8042830 | Seed | 1632691 | 8594742 |
View details of Endostart's funding rounds and investors
Endostart's founders and board of directors
Founder? Claim ProfileThe founders of Endostart is Alessandro Tozzi. Alberto Bruni is the CEO of Endostart.
Here are the details of Endostart's key team members:
- Alessandro Tozzi: Founder & MD of Endostart. Contact Info: 1 email address
- Alberto Bruni: CEO of Endostart. Contact Info: 1 email address
View details of Endostart's Founder profiles and Board Members
Endostart's employee count trend
Endostart has 19 employees as of Jun 26. Here is Endostart's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Endostart's Competitors and alternates
Top competitors of Endostart include Augmedics, ClearPoint Neuro and Proprio. Here is the list of Top 10 competitors of Endostart, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Provider of an augmented reality guidance system for surgery | $143M | 69/100 | ||
2nd | ClearPoint Neuro 1998, Irvine (United States), Public | Developer of MRI-guided stereotactic system for neurological interventions | $33.7M | 64/100 | |
3rd | Proprio 2016, Seattle (United States), Series B | Developer of visualization system for surgeries | $74.2M | 64/100 | |
4th | Intellijoint 2010, Waterloo (Canada), Series A | Developer of 3D surgical navigation tools for hip and knee replacements | $24.7M | 61/100 | |
5th | HRS Navigation 2015, Bengaluru (India), Seed | Manufacturer of surgical navigation systems for cranial, spinal, and ENT surgeries | $7.58M | 61/100 | |
6th | Accelus 2016, Palm Beach Gardens (United States), Series D | Provider of spine surgery robot systems for healthcare industries | $20.8M | 60/100 | |
7th | MediView 2017, Cleveland (United States), Series A | Digital medical image management tool for providers | $117M | 58/100 | |
8th | Centerline Biomedical 2014, Cleveland (United States), Series B | Developer of surgical navigation and image guidance system for endovascular procedures | $76.3M | 57/100 | |
9th | Dilon Diagnostics 1999, Newport News (United States), Series A | Developer of technology for molecular breast imaging | $32.1M | 56/100 | |
10th | MRI Interventions 1998, Irvine (United States), Public | MRI-guided surgery platform | $16.5M | 56/100 | |
38th | Developer of a guiding system for colonoscopy procedures | $19.2M | 41/100 |
Looking for more details on Endostart's competitors? Click here to see the top ones
Endostart's Investments and acquisitions
Endostart has made no investments or acquisitions yet.
Reports related to Endostart
Here is the latest report on Endostart's sector:
News related to Endostart
•
Kairos Partners SGR’s Investment In The MedTech Start-up EndostartGlobal Legal Chronicle•Sep 12, 2022•CMPlaw, Endostart, Kairos
•
Endostart appoints Christopher Rowland as Chairman of the company's Board of DirectorsBusiness Wire•Jul 15, 2022•Endostart, Boston Scientific
•
Endostart Raises €1M in Seed FundingFinSMEs•Dec 20, 2018•Endostart, Panakes Partners, Estor, A11 Venture
Are you a Founder ?
FAQs about Endostart
Explore our recently published companies
- Salmonandsable - Unfunded company
- Order Asprigofthymesrq - Unfunded company
- Pizzatupwalthamabbey - United Kingdom based, Unfunded company
- Damascusbakeryandsweets - United Kingdom based, Unfunded company
- Alifishandchips - United Kingdom based, Unfunded company
- Pasam Pizza Kebab - Germany based, Unfunded company
